Solvay Q3 2026 underlying EBITDA falls 25% year over year to €173 million

PUBT · 20h ago
Solvay Q3 2026 underlying EBITDA falls 25% year over year to €173 million
  • Solvay’s Q3 2026 underlying EBITDA fell 25% year over year to €173 million, hurt by Middle East conflict and soda ash weakness.
  • Underlying net sales declined to €1.03 billion, with pricing gains and favorable currency movements offsetting some volume weakness.
  • Operations at the HPPO site in Saudi Arabia remain halted, while strong growth in electronic-grade peroxides continues.
  • The revised 2026 outlook targets underlying EBITDA of €720 million–€740 million, excluding potential revenue or recovery measures from Sadara.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Solvay SA published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.